The primary structure of a bacteriocin produced by Enterococcus hirae DCH5 was determined by combined amino acid and DNA sequencing. Nucleotide analysis of a 2838-bp DNA fragment of E. hirae DCH5 revealed five putative ORFs. The first orf (hirJM79) encodes a 74-amino-acid peptide containing an N-terminal signal peptide of 30 amino acids, followed by the amino acid sequence of the mature bacteriocin, hiracin JM79 (HirJM79), of 44 amino acids. The second orf (hiriJM79) encodes the putative immunity protein of HirJM79. Contiguous ORFs encode a putative mobilization protein (orfC), a relaxase/mobilization nuclease domain (orfD), and a hypothetical protein (orfE). The production and functional expression of HirJM79 by heterologous hosts suggest that hirJM79 is the minimum requirement for production of biologically active HirJM79, that HirJM79 is most likely externalized by the general secretory pathway or sec-dependent pathway, and that HiriJM79 is the immunity protein for HirJM79.
Introduction
Enterococci are widespread in nature and constitute an essential part of the endogenous gut microbiota of humans and animals. However, their presence in food is controversial: enterococci are considered as indicators of faecal contamination and responsible for food spoilage, but also beneficial for their potential use as starter cultures in food fermentation, their use as probiotics, and their ability to produce ribosomally synthesized antimicrobial peptides generally referred to as bacteriocins (Cintas et al., 2001; Eijsink et al., 2002) . Bacteriocin-producing lactic acid bacteria (LAB), including enterococci, are widespread in nature (Foulquié-Moreno et al., 2005) , and since bacteriocins may inhibit Gram-positive food-spoilage and food-borne pathogenic bacteria, they are an important choice as natural and nontoxic food preservatives (Cotter et al., 2005) . Most bacteriocins from LAB are synthesized as biologically inactive prepeptides containing an N-terminal extension. The mature peptides are often cationic, amphiphilic, membranepermeabilizing molecules, and are classified into two main classes. Class I consists of modified bacteriocins, the lantibiotics. Class II is comprised of nonmodified, heat-stable bacteriocins, which are divided into subclasses IIa (pediocin-like, strong antilisterial bacteriocins), IIb (two-peptide bacteriocins), IIc (cyclic structures), and IId (other peptide bacteriocins) (Cotter et al., 2005; Fimland et al., 2005) . The N-terminal extensions of the prepeptide of some lantibiotics and most nonlantibiotics are of the so-called double-glycine type (leader sequence) and are cleaved off concomitantly with export across the cytoplasmic membrane by dedicated ABC-transporters and their accessory proteins (Håvarstein et al., 1995) . However, some class II bacteriocins contain Nterminal extensions of the so-called sec-type (signal peptide), which are proteolytically cleaved concomitantly with bacteriocin externalization by the general secretory pathway or sec-dependent pathway (Van Wely et al., 2001; Herranz & Driessen, 2005) .
Enterococci in food may be beneficial by producing antimicrobial agents and by improving the perceptible quality of food for consumers. They may also represent a concern because of nosocomial and opportunistic infections.
The safety of foods containing enterococci is an issue that the food industry must carefully address (Martín et al., 2006) . Thus, it is of interest to evaluate the hygienic and safety aspects related to the presence of enterococci in wild animal species suitable for human consumption. Enterococci isolated from carcasses and the intestinal content of mallard ducks (Anas platyrhynchos) have been evaluated with respect to antimicrobial compounds, the presence of genes encoding bacteriocins and their expression, and potential virulence factors. Enterococcus hirae DCH5 was considered safe due to its antagonistic activity, the absence of virulence genes, and susceptibility to most clinically relevant antibiotics. Purification of the antimicrobial activity of E. hirae DCH5 resulted in a single peptide absorbance peak, which after MALDI-TOF MS analysis showed a major mass peak of 5093.2 Da, suggesting that the antagonistic peptide was purified to homogeneity (J. Sánchez, A. Basanta, B. Gómez-Sala, C. Herranz, L.M. Cintas, and P.E. Hernández, submitted for publication). This study reports the amino acid and nucleotide sequence, adjacent genes, and heterologous expression of a sec-dependent bacteriocin produced by E. hirae DCH5.
Materials and methods

Bacterial strains and media, and growth conditions
The bacteriocin producer E. hirae DCH5 was isolated from wild Mallard ducks (A. platyrhynchos), and identified using genus-and species-specific PCR primers (J. Sánchez, A. Basanta, B. Gómez-Sala, C. Herranz, L.M. Cintas, and P.E. Hernández, submitted for publication), and by comparing its whole-cell protein profile with protein profiles of LAB previously described by Marc Vancanneyt, University of Ghent (BCCM/LMG Culture Collection, Ghent, Belgium). Enterococcus faecium T136 , other LAB, and food-spoilage and food-borne pathogenic bacteria were used as indicators of the antimicrobial activity of E. hirae DCH5 (Table 1 ). All LAB strains were grown in de Man, Rogosa and Sharpe (MRS) broth (Oxoid Ltd., Basingstoke, UK) at 32 1C. Listeria spp. and Staphylococcus spp. were propagated in brain heart infusion (BHI) medium (Oxoid) at 32 1C. Propionobacterium spp. and Clostridium spp. were propagated in BHI medium (Oxoid) at 32 and 37 1C, respectively, in anaerobic jars. Brocothrix thermosphacta and Pseudomonas fluorescens were grown in tryptone soya broth (TSB) medium (Oxoid) at 32 1C. Lactobacillus sakei Lb790 (Schillinger & Lucke, 1989) , Enterococcus faecalis JH2-2 (Jacob & Hobbs, 1974) , and E. faecium L50/14-2 were also propagated in MRS broth at 32 1C, while Lactococcus lactis ssp. lactis IL1403 (Chopin et al., 1984) was propagated in M17 broth (Oxoid) supplemented with 0.5% (w/v) glucose (GM17) at 32 1C. Transformants of Lactococcus lactis IL1403, Lactobacillus sakei Lb790, E. faecalis JH2-2, and E. faecium L50/14-2 were selected with 5 mg mL À1 of chloramphenicol (Sigma Chemical Co., St Louis, MO). Cell-free culture supernatants were obtained by centrifugation of E. hirae DCH5 at 12 000 g at 4 1C for 10 min, adjusted to pH 6.2 with 1 M NaOH, filtered through 0.25 mm poresize sterile syringe filters (Whatman Int. Ltd., Maidstone, UK), and stored at À 20 1C. The antagonistic activity of E. hirae DCH5 was evaluated by the agar diffusion test (ADT) and, when stated, by a microtiter plate assay (MPA), performed as previously described (Cintas et al., 2000) .
Amino acid and nucleotide sequencing of the bacteriocin produced by E. hirae DCH5, and adjacent genes
The purified antimicrobial activity of E. hirae DCH5 was subjected to N-terminal amino acid sequencing by Edman degradation, using a 477A automatic sequencer (Applied Biosystems, Foster City, CA) with an on-line 120A phenylthiohydantoin amino acid analyser. For DNA sequencing, total DNA from E. hirae DCH5 was obtained using Advamax beads (Advanced Genetic Technologies Corp., Gaithersburg, MD), digested with the blunt-end restriction enzymes BsaAI, EcoRV, PvuII and DraI (New England BioLabs, Beverley, MA), and ligated to the EcoRV-digested pCR-Blunt II-TOPO sequencing vector (Invitrogen Life Technologies, Norway). These ligation mixtures were used as templates for PCRs, which were carried out with combinations of degenerate primers based on the deduced Nterminal amino acid sequence of the purified antimicrobial peptide of E. hirae DCH5, and a vector-specific primer ( Table 2 ). The PCR-generated fragments were analyzed by agarose gel electrophoresis, purified using a QIAquick PCR Purification Kit (QIAGEN, Hilden, Germany), and sequenced with an ABI PRISM BigDye TM Terminator cycle sequencing reaction kit, and the automatic DNA sequencer ABI PRISM, model 377 (Applied Biosystems, Foster City, CA). Homology searches of the DNA sequences were performed with the BLAST algorithm (Altschul et al., 1997) available at the National Center for Biotechnology Information (NCBI). For isolation and purification of resident plasmids, cultures of E. hirae DCH5 and Lactococcus lactis IL1430 were processed with the QIAGEN Plasmid Mini Kit (QIAGEN) and the QIAGEN Plasmid Midi Kit (QIAGEN), as described by the manufacturer, with addition of lysozyme (40 mg mL
À1
) and mutanolysin (500 U mL À1 ).
Cloning of the bacteriocin produced by E. hirae DCH5
Total DNA from E. hirae DCH5 was isolated using the Wizard s DNA Purification Kit (Promega, Madison, WI).
Plasmid pMG36c (Van de Guchte et al., 1989) was used as the expression plasmid for cloning of the E. hirae DCH5 structural gene (hirJM79) coding the bacteriocin HirJM79, with or without its putative immunity gene (hiriJM79). The primers and inserts used for construction of the recombinant plasmids are listed in Table 3 . Derivatives of plasmid pMG36c were constructed as follows. Primers HirA-F and HirA-R were used to amplify a 711-bp (fragment THi) carrying the structural (hirJM79), and putative immunity (hiriJM79) genes of HirJM79 from total DNA of E. hirae 
DCH5
. Primers HPJ-F and HPJE-R were used for PCRamplification, from fragment THi, of a 270-bp SacI-HindIII fragment (insert HE) containing the P 32 and ribosomal binding site (RBS) of pMG36c and hirJM79. Primers HPJ-F and HPJEI-R were used for PCR-amplification, from the same DNA target, of a 577-bp SacI-HindIII fragment (insert HEi), containing the P 32 and RBS of pMG36c and the hirJM79 and hiriJM79 genes. Fragments HE and HEi were digested with the indicated restriction enzymes and inserted in pMG36c cut with the same enzymes. The ligation mixtures were used to transform competent Lactococcus lactis ssp. lactis IL1403 cells according to the method of Holo & Nes (1989) , with a Gene Pulser TM and Pulse Controller apparatus (Bio-Rad Laboratories, Hercules, CA). The proper clones, containing pJPH1 (hirJM79) or pJPH2 (hirJM791hiriJM79), were checked for bacteriocin production, PCR, and sequencing of the inserts. The control and recombinant plasmids were reisolated from Lactococcus lactis IL1430 and then transferred to Lactobacillus sakei Lb790, E. faecalis JH2-2, and E. faecium L50/14-2 by electroporation as previously described (Holo & Nes, 1989; Aukrust et al., 1995) .
Results
Antimicrobial spectrum of the bacteriocin produced by E. hirae DCH5 When cell-free culture supernatants and the purified bacteriocin produced by E. hirae DCH5 were tested against different indicator microorganisms, most of them were sensitive to their antagonistic activity, the antimicrobial effect of the purified bacteriocin was higher, and the number of sensitive indicators larger (Table 1) . None of the Gram-negative bacteria tested were sensitive to the antagonistic activity of E. hirae DCH5. However, the bacteriocin produced by E. hirae DCH5 inhibits a diverse number of food-spoilage and food-borne pathogenic bacteria (Fig. 1) . The first orf, termed hirJM79, encodes a 74-amino-acid protein containing a 30-amino-acid N-terminal peptide followed by the amino acid sequence of the purified bacteriocin, hiracin JM79 (HirJM79), of 44 amino acids (Fig. 2) . The molecular weight of mature HirJM79 was calculated to be 5093.7 which is almost identical to the MALDI-TOF MS data of the purified bacteriocin (5093.2). The ATG start codon is preceded by a potential RBS, and a À 10 and À 35 consensus promoter region. Two sets of inverted repeats rich in AT were also present in the promoter region, and may serve as putative binding sites for transcriptional regulators . A second orf, denominated hiriJM79, encoding a protein of 95 amino acids was identified 20 nucleotides downstream of the stop codon of hirJM79. The ATG start codon is preceded by a potential RBS, and this orf probably encodes the putative immunity protein of HirJM79 as it is located immediately downstream of the structural gene hirJM79, which is a common feature of LAB bacteriocin operons (Nes et al., 1996) . The third orf, orfC, located c. 430 bp downstream of the stop codon of hiriJM79, encodes a putative 129-amino-acid protein. The fourth orf, orfD, located c. 800 bp downstream of the stop codon of hiriJM79 and overlapping with the end of orfC, encodes a protein of 304 amino acids. The incompletely sequenced orfE, situated c. 1960-bp downstream of the stop codon of hiriJM79, displays a 100% identity with the first 26 amino acid residues of a hypothetical protein of 229 amino acids, as reported in E. faecium DO (GenBank, accession number AAAK03000087).
Heterologous production and functional expression of hiracin JM79 in Lactococcus lactis , Lactobacillus sakei , E. faecalis , and E. faecium When derivatives of plasmid pMG36c, termed pJPH1 (hirJM79) and pJPH2 (hirJM791hiriJM79), carrying the structural and the structural plus the putative immunity genes of HirJM79, respectively, were used to transform competent Lactococcus lactis ssp. lactis IL1403 cells resistant to HirJM79 (Hir R ), it was observed that while supernatants of the control strain Lactococcus lactis IL1403 (pMG36c) did not exert an antagonistic effect, the supernatants of the recombinant Lactococcus lactis IL1403 (pJPH1) and Lactococcus lactis IL1403 (pJPH2) hosts showed a potent antimicrobial activity against E. faecium T136 (Fig. 3a) . The halos of inhibition produced by Lactococcus lactis IL1043 derivatives, carrying either pJPH1 or pJPH2, were similar to those produced by E. hirae DCH5, producer of HirJM79, and of E. faecium P13, producer of enterocin P (EntP). Similarly, when the recombinant plasmids from the Lactococcus lactis IL1430 derivatives were transferred to Lactobacillus sakei Lb790, also a Hir R strain, the supernatants of Lactobacillus sakei Lb790 (pJPH1) and Lactobacillus sakei Lb790 (pJPH2), also showed a defined antagonistic activity against E. faecium T136 (Fig. 3a) .
However, when the recombinant plasmids pJPH1 and pJPH2 were transferred to E. faecalis JH2-2 and E. faecium L50/14-2, both sensitive to HirJM79 (Hir S ), only transformed cells derived from pJPH2 (hirJM791hiriJM79) but not from pJPH1 (hirJM79) were obtained. The halos of inhibition produced by E. faecalis (pJPH2) and E. faecium L50/14-2 (pJPH2), were similar or even greater than those produced by the Lactococcus lactis (Hir R ) and Lactobacillus (
(C) . Antimicrobial activity of supernatants of: (g) Enterococcus faecalis JH2-2 (pMG36c), (h) E. faecalis JH2-2 (pJPH2), (i) Enterococcus faecium L50/14-2 (pMG36c), (j) E. faecium L50/ 14-2 (pJPH2), (k) E. faecium P13, and (j) Enterococcus hirae DCH5. The antimicrobial activity of all supernatants was determined by the agar well diffusion test with E. faecium T136 as the indicator strain. (C). Antimicrobial activity of a supernatant of E. hirae DCH5 as determined by the agar well diffusion test with: (m) E. faecalis JH2-2 (pMG36c), (n) E. faecalis JH2-2 (pJPH2), (o) E. faecium L50/14-2 (pMG36c), and (p) E. faecium L50/14-2 (pJPH2) as the indicator strains.
sakei (Hir R ) hosts. The inhibition displayed by E. faecium L50/14-2 (pMG36c) is ascribed to its production of enterocin P , while the small antagonistic effect of the supernatant of E. faecalis (pMG36c) would be ascribed to still unknown molecules with antagonistic activity (Fig. 3b) . Furthermore, when the E. faecalis JH2-2 and the E. faecium L50/14-2 derivatives, either carrying pMG36c or pJPH2, were used as indicators of the antimicrobial activity of E. hirae DCH5, producer of HirJM79, it was observed that while the E. faecalis and the E. faecium hosts transformed with pMG36c were sensitive to HirJM79, those transformed with pJPH2 were immmune to its activity (Fig. 3c) .
Discussion
The analysis of the amino acid sequence of mature HirJM79, deduced from their nucleotide sequence, matches that obtained by Edman degradation except the presence of Thr instead of Gly at position 2, and the presence of Trp, Trp, Gln, Trp, His, and Trp at positions 16, 19, 21, 34, 37 and 40, respectively. Furthermore, such amino acid sequence contained two additional C-terminal amino acids (two Arg residues at positions 43 and 44), as compared with the sequence obtained by Edman degradation. The mature HirJM79 also contains a consensus amino acid sequence at the N-terminal region, which is a common motif among the pediocin-like bacteriocins ('pediocin box', Tyr-Gly-Asn-GlyVal), except for a Leu residue instead of the Val residue, and it also contains the two conserved cysteine residues always found in the N-terminal part of such bacteriocins. Hiracin JM79 is a cationic peptide with a pI of 9.1. Following the Nterminal methionine, the N-terminal extension of HirJM79 contains three positively charged amino acids (Lys-Lys-Lys), a span of hydrophobic amino acids, and two small and hydrophobic amino acids at positions À 1 and À 3 relative to the cleavage site (Ala and Val, respectively). This sequence confers a typical signal peptide for proteins processed and secreted by the sec-dependent pathway (Von Heijne, 1983; Worobo et al., 1995) . Therefore, the bacteriocin produced by E. hirae DCH2 is most likely synthesized as a prepeptide that is cleaved through the Val-Asp-Ala residues (positions À 3 to À 1) releasing the mature HirJM79.
A BLAST protein sequence homology search revealed that HirJM79 was identical to bacteriocin T8 (100% identity; GenBank, accession number DQ402539), produced by E. faecium T8 isolated from vaginal secretions of children infected with HIV (De Kwaadsteniet et al., 2006) . The mature HirJM79 also reveals a high homology with bacteriocin RC714 (identical to HirJM79 except for the absence of the last two amino acids), produced by E. faecium RC714 isolated from a human exudate sample (Del Campo et al., 2001) . The mature HirJM79 also reveals homology with the sec-dependent bacteriocin 31 (69% identity) produced by E. faecalis YI717 (Tomita et al., 1996) , and with the secdependent enterocin P (47% identity) produced by E. facium P13 . Homology searches of the deduced HiriJM79 peptide, encoded by the second orf, denominated hiriJM79, revealed a 100% identity with the putative immunity protein of bacteriocin T8 (De Kwaadsteniet et al., 2006) , and a 50% identity with the putative immunity protein of bacteriocin 31 (Tomita et al., 1996) . The timely and independent characterization by unrelated research groups of bacteriocins produced by LAB is unexpected but not infrequent in the bacteriocin research field. Pediocin AcH produced by Pediococcus acidilactici H (Motlagh et al., 1992) , was shown to be identical to pediocin PA-1 produced by P. acidilactici PAC1.0 (Marugg et al., 1992) , whereas curvacin A produced by Lactobacillus curvatus LTH1174 (Tichaczek et al., 1992) is also identical to sakacin A produced by Lactobacillus sakei Lb706 (Holck et al., 1992) , and these bacteriocins are recognized in scientific literature as pediocin AcH/pediocin PA-1, and curvacin A/sakacin A. Since HirJM79 is produced by a distinct enterococcal species, namely E. hirae DCH5, isolated from a very unrelated ecological niche as compared with bacteriocin T8, produced by E. faecium T8 (De Kwaadsteniet et al., 2006) , these bacteriocins would be recognized as hiracin JM79/bacteriocin T8.
The third orf, orfC, encodes a putative protein that mostly resembles (97% identity) a mobilization protein from E. faecium DO (GenBank, accession number AAA03000087), and the mobilization protein MobC (43% identity) from E. faecalis BFE 1071 (Balla et al., 2000; Balla & Dicks, 2005) . Sequence features typical of a transfer origin (oriT) (Francia et al., 2004; Smith & Thomas, 2004) are found in the region containing the putative promoter of orfC, including two inverted repeats and a sequence (GAGCTTGC) with homology to the core sequence of the cis-acting nic site of the IncP/ Mob p family of Gram-positive plasmids (Smith & Thomas, 2004; Criado et al., 2006) . The fourth orf, orfD, encodes a protein showing a high sequence homology (99% identity) with the relaxase/mobilization nuclease domain described in the enterocin Q-encoding plasmid pCIZ2 from the multiple bacteriocin producer E. faecium L50 , with an analogous domain (93% identity) described in E. faecium DO (GenBank, accession number AAK03000087), and with the mobilization protein MobA (44% identity) from E. faecalis BFE 1071 (Balla & Dicks, 2005) . Typical features for this protein family is the presence of three highly conserved motifs (I, II, and III) at the N-terminal relaxase domain (Francia et al., 2004) . Interestingly, the homology of the ORFD encoded by E. hirae DCH5 shows a larger homology (93% identity) toward the relaxase/mobilization nuclease domain of E. faecium DO, that the 75% identity described for the ORF4 encoded next to bacteriocin T8 (De Kwaadsteniet et al., 2006) for the same nuclease domain of E. faecium DO, suggesting that the ORFD protein encoded next to HirJM79 and the ORF4 protein, encoded next to bacteriocin T8, may not be identical.
Our study includes the sequence of 2838 contiguous nucleotides of the hiracin JM79 operon, a putative mobilization protein, a relaxase/mobilization nuclease domain, and an hypothetical protein, although the genes downstream of the structural HirJM79 gene may not be identical to those in the vicinity of bacteriocin T8. Moreover, no resident plasmids were found in E. hirae DCH5, suggesting that this gene cluster is integrated in the genome. However, the presence of a mobilization protein, a relaxase and a possible oriT sequence in the vicinity of genes coding HirJM79, and its putative immunity protein (HiriJM79) suggests that further efforts may be performed toward elucidation of the complete genetic structure of the DNA fragment coding these and, maybe, other related functions, which may contribute to their transfer and mobilization among enterococci. Little is known about the evolutionary relationships among bacteriocins from different bacteria, but conservation of bacteriocin gene clusters suggest that production of bacteriocins confers selective advantages to the producer strain. Further efforts would be performed toward elucidation of the mechanisms of transfer and mobilization of bacteriocin gene clusters among LAB, including those relative to hiracin JM79, bacteriocin T8 (De Kwaadsteniet et al., 2006) , and bacteriocin RC714 (Del Campo et al., 2001 ) encoded by distinct enterococci from different ecological niches.
All recombinant Lactococcus lactis IL1403 and Lactobacillus sakei Lb790 strains, resistant to HirJM79 (Hir R ) and carrying either pJPH1 (hirJM79) or pJPH2 (hirJM791hir-iJM79), displayed extracellular antagonistic activity, suggesting that hirJM79 is the minimum requirement for production of biologically active HirJM79 even in the absence of the putative immunity peptide HiriJM79. When HirJM79 produced by Lactococcus lactis IL1403 (pJPH1) was purified to homogeneity, a peptide fragment of the molecular mass of HirJM79, as produced by E. hirae DCH5, was obtained (results not shown). However, the failure to obtain transformants from the E. faecalis JH2-2 and E. faecium L50/ 14-2 strains, sensitive to HirJM79 (Hir S ), and transformed with pJPH1 and the observation that the same strains transformed with pJPH2 showed extracellular antagonistic activity and are immune to the antagonistic effect of HirJM79, suggest that HiriJM79 is the immunity protein for HirJM79. The results obtained also suggest that HirJM79 is efficiently processed in recombinant Lactococcus lactis, Lactobacillus sakei, E. faecalis, and E. faecium cells, and that the bacteriocin is most likely externalized by the general secretory pathway or sec-dependent pathway of the host cells. Previously described sec-dependent bacteriocins produced by LAB includes acidocin B, divergicin A, bacteriocin 31, enterocin P, lactococcin 972, propionicin T1, and enterolysin A .
As shown in this study, E. hirae DCH5, a bacteriocin producing Enterococcus isolated from Mallard ducks (A. platyrhynchos), produces a highly active, sec-dependent antimicrobial peptide hiracin JM79/bacteriocin T8. The increase in the antimicrobial activity of HirJM79, during its purification, may be the result of removal of antimicrobial inhibitors, disaggregation of the bacteriocin or conformational change to a more active form of the bacteriocin in the hydrophobic solvent (Gutiérrez et al., 2004) . However, the potential use of enterococci as producers of bacteriocins must be cautioned as many Enterococcus isolates code for potential virulence factors (Eaton & Gasson, 2001; Franz et al., 2001; Martín et al., 2006) , and are involved in human infections and antibiotic resistance (Pillar & Gillmore, 2004; Martín et al., 2006) . Nevertheless, E. hirae DCH5 and its bacteriocin, hiracin JM79/bacteriocin T8, might have biotechnological interest as natural antimicrobial agents in medical applications and/or in the food and feed industry. However, before an evaluation of their potential applications, other safety and/or technological characteristics of this strain, and its bacteriocin, would be investigated.
